1. Antidepressive effects of targeting ELK-1 signal transduction. (May 2018) Authors: Apazoglou, Kallia; Farley, Séverine; Gorgievski, Victor; Belzeaux, Raoul; Lopez, Juan; Grenier, Julien; Ibrahim, El; El Khoury, Marie-Anne; Tse, Yiu; Mongredien, Raphaele; Barbé, Alexandre; Macedo, Carlos; Jaworski, Wojciech; Bochereau, Ariane; Orrico, Alejandro; Isingrini, Elsa; Guinaudie, Chloé... Journal: Nature medicine Issue: Volume 24:Number 5(2018) Page Start: 591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial. Issue 5 (May 2020) Authors: Pfisterer, Jacobus; Shannon, Catherine M; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P; Hein, Alexander; Zeimet, Alain G; Hanker, Lars C; Petit, Thierry; Marmé, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de... Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of physical exercise on brain and lipid metabolism in mouse models of multiple sclerosis. (October 2017) Authors: Houdebine, Léo; Gallelli, Cristina Anna; Rastelli, Marialetizia; Sampathkumar, Nirmal Kumar; Grenier, Julien Journal: Chemistry and physics of lipids Issue: Volume 207(2017)Part B Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study. (December 2020) Authors: Hardy-Bessard, Anne-Claire; Brocard, Fabien; Clatot, Florian; Lortholary, Alain; You, Benoît; Grenier, Julien; Martin-Babau, Jérôme; Lucas, Brigitte; Meunier, Jérôme; Ferrero, Jean-Marc; Savoye, Aude-Marie; Marti, Adina; Despax, Raymond; Moullet, Isabelle; Emile, George Journal: Breast Issue: Volume 54(2020) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Liver X Receptors differentially modulate central myelin gene mRNA levels in a region-, age- and isoform-specific manner. Issue 169 (May 2017) Authors: Shackleford, Ghjuvan' Ghjacumu; Grenier, Julien; Abi Habib, Walid; Massaad, Charbel; Meffre, Delphine Journal: Journal of steroid biochemistry and molecular biology Issue: Issue 169(2017) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial. Issue 11 (November 2022) Authors: Bidard, François-Clément; Hardy-Bessard, Anne-Claire; Dalenc, Florence; Bachelot, Thomas; Pierga, Jean-Yves; de la Motte Rouge, Thibault; Sabatier, Renaud; Dubot, Coraline; Frenel, Jean-Sébastien; Ferrero, Jean Marc; Ladoire, Sylvain; Levy, Christelle; Mouret-Reynier, Marie-Ange; Lortholary, Alai... Journal: Lancet oncology Issue: Volume 23:Issue 11(2022) Page Start: 1367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗